RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Oligodendroglioma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 51 pages - $1,000
Oligodendroglioma - Pipeline Review, Q4 2010
Dec 2010 - 23 pages - $500
Brain Cancer - Pipeline Review, Q3 2011
Jul 2011 - 327 pages - $500
Oligodendroglioma - Pipeline Review, Q2 2011
Apr 2011 - 68 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
ZIOPHARM Oncology Inc: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 40 pages - $495
Oligodendroglioma - Pipeline Review, H2 2011
Aug 2011 - 70 pages - $500
Cougar Biotechnology Inc: Premium Company Profile
Apr 2008 - 39 pages - $495
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Company Financials: Cougar Biotechnology, Inc.
Jan 2010 - $75
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Oncology del
Brain cancer del
Oligodendroglioma del
Year
2002 del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Manufacturing
Nanotechnology
Other
Research supplies
Stem cells

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us